Humana AB (Sweden) Performance
| HUM Stock | SEK 47.40 0.60 1.25% |
The company retains a Market Volatility (i.e., Beta) of 0.28, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Humana AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding Humana AB is expected to be smaller as well. At this point, Humana AB has a negative expected return of -0.0506%. Please make sure to check out Humana AB's sortino ratio, skewness, period momentum indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Humana AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Humana AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, Humana AB is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 759 M | |
| Total Cashflows From Investing Activities | -260 M |
Humana |
Humana AB Relative Risk vs. Return Landscape
If you would invest 4,910 in Humana AB on November 1, 2025 and sell it today you would lose (170.00) from holding Humana AB or give up 3.46% of portfolio value over 90 days. Humana AB is producing return of less than zero assuming 1.4358% volatility of returns over the 90 days investment horizon. Simply put, 12% of all stocks have less volatile historical return distribution than Humana AB, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Humana AB Target Price Odds to finish over Current Price
The tendency of Humana Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 47.40 | 90 days | 47.40 | about 65.81 |
Based on a normal probability distribution, the odds of Humana AB to move above the current price in 90 days from now is about 65.81 (This Humana AB probability density function shows the probability of Humana Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Humana AB has a beta of 0.28. This usually indicates as returns on the market go up, Humana AB average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Humana AB will be expected to be much smaller as well. Additionally Humana AB has an alpha of 0.1565, implying that it can generate a 0.16 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Humana AB Price Density |
| Price |
Predictive Modules for Humana AB
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Humana AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Humana AB Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Humana AB is not an exception. The market had few large corrections towards the Humana AB's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Humana AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Humana AB within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.16 | |
β | Beta against Dow Jones | 0.28 | |
σ | Overall volatility | 1.94 | |
Ir | Information ratio | 0.07 |
Humana AB Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Humana AB for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Humana AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Humana AB generated a negative expected return over the last 90 days | |
| Humana AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Humana AB has accumulated 4.7 B in total debt with debt to equity ratio (D/E) of 200.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Humana AB has a current ratio of 0.77, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Humana AB until it has trouble settling it off, either with new capital or with free cash flow. So, Humana AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Humana AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Humana to invest in growth at high rates of return. When we think about Humana AB's use of debt, we should always consider it together with cash and equity. | |
| About 72.0% of Humana AB shares are owned by institutional investors |
Humana AB Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Humana Stock often depends not only on the future outlook of the current and potential Humana AB's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Humana AB's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.7 M | |
| Cash And Short Term Investments | 695 M |
Humana AB Fundamentals Growth
Humana Stock prices reflect investors' perceptions of the future prospects and financial health of Humana AB, and Humana AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Humana Stock performance.
| Return On Equity | 0.0794 | |||
| Return On Asset | 0.0292 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 6.55 B | |||
| Shares Outstanding | 47.83 M | |||
| Price To Earning | 13.39 X | |||
| Price To Book | 0.71 X | |||
| Price To Sales | 0.22 X | |||
| Revenue | 8.19 B | |||
| EBITDA | 912 M | |||
| Cash And Equivalents | 695 M | |||
| Cash Per Share | 9.20 X | |||
| Total Debt | 4.7 B | |||
| Debt To Equity | 200.80 % | |||
| Book Value Per Share | 57.27 X | |||
| Cash Flow From Operations | 689 M | |||
| Earnings Per Share | 6.27 X | |||
| Total Asset | 9 B | |||
| Retained Earnings | 440 M | |||
| Current Asset | 1.21 B | |||
| Current Liabilities | 1.06 B | |||
About Humana AB Performance
Assessing Humana AB's fundamental ratios provides investors with valuable insights into Humana AB's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Humana AB is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Humana AB , together with its subsidiaries, provides individual and family care services for children, adolescents, and adults in Sweden, Norway, Denmark, and Finland. Humana AB was founded in 2001 and is headquartered in Stockholm, Sweden. Humana AB operates under Personal Services classification in Sweden and is traded on Stockholm Stock Exchange. It employs 11238 people.Things to note about Humana AB performance evaluation
Checking the ongoing alerts about Humana AB for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Humana AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Humana AB generated a negative expected return over the last 90 days | |
| Humana AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Humana AB has accumulated 4.7 B in total debt with debt to equity ratio (D/E) of 200.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Humana AB has a current ratio of 0.77, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Humana AB until it has trouble settling it off, either with new capital or with free cash flow. So, Humana AB's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Humana AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Humana to invest in growth at high rates of return. When we think about Humana AB's use of debt, we should always consider it together with cash and equity. | |
| About 72.0% of Humana AB shares are owned by institutional investors |
- Analyzing Humana AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Humana AB's stock is overvalued or undervalued compared to its peers.
- Examining Humana AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Humana AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Humana AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Humana AB's stock. These opinions can provide insight into Humana AB's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Humana Stock Analysis
When running Humana AB's price analysis, check to measure Humana AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humana AB is operating at the current time. Most of Humana AB's value examination focuses on studying past and present price action to predict the probability of Humana AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humana AB's price. Additionally, you may evaluate how the addition of Humana AB to your portfolios can decrease your overall portfolio volatility.